Genzyme Molecular in drug discovery with Purdue

GZMO and Purdue Pharma (Stamford, Conn.) will develop up to 20 cancer antigens. GZMO said it will receive $21 million in committed funding from Purdue, including a $12 million upfront payment, technol...